title: Impact of body mass index on incidence of febrile neutropenia and treatment-related mortality in United States veterans with diffuse large B-cell lymphoma receiving rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone.
authors.affiliation: Saint Louis Veterans Affairs Medical Center, Research Service, Saint Louis, MO, USA; Washington University School of Medicine, Saint Louis, MO, USA.
authors.forename: Arun
authors.initials: A
authors.lastname: Ganti
authors.forename: Weijian
authors.initials: W
authors.lastname: Liu
authors.forename: Suhong
authors.initials: S
authors.lastname: Luo
authors.forename: Kristen M
authors.initials: KM
authors.lastname: Sanfilippo
authors.forename: Ryan
authors.initials: R
authors.lastname: Roop
authors.forename: Ryan
authors.initials: R
authors.lastname: Lynch
authors.forename: Peter
authors.initials: P
authors.lastname: Riedell
authors.forename: Katiuscia
authors.initials: K
authors.lastname: O'Brian
authors.forename: Graham A
authors.initials: GA
authors.lastname: Colditz
authors.forename: Kenneth R
authors.initials: KR
authors.lastname: Carson
mesh_terms: D000368:Aged; D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage / Q000009:adverse effects; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects; D015992:Body Mass Index; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects; D004317:Doxorubicin / Q000008:administration & dosage / Q000009:adverse effects; D064147:Febrile Neutropenia / Q000139:chemically induced / Q000188:drug therapy / Q000401:mortality; D005260:Female; D006801:Humans; D015994:Incidence; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy / Q000401:mortality; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000008:administration & dosage / Q000009:adverse effects; D012189:Retrospective Studies; D000069283:Rituximab; D014481:United States / Q000453:epidemiology; D014728:Veterans; D014750:Vincristine / Q000008:administration & dosage / Q000009:adverse effects
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; C571759:R-CHOP protocol; D000069283:Rituximab; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone
keywords: diffuse large B-cell lymphoma; empiric dose-reduction; non-Hodgkin lymphoma; obesity; treatment-related toxicity